Related Experiment Videos
Autonomic effects of vasoactive drugs: physiological insights and clinical implications
1Mayo Clinic, Department of Medicine, Division of Hypertension, Rochester, Minnesota, USA.
Journal of Hypertension
|May 23, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Updated Integrated Safety Analysis of Ritlecitinib up to ~ 5 Years in Patients with Alopecia Areata from the ALLEGRO Clinical Trial Program.
American journal of clinical dermatology·2026
Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies.
American journal of clinical dermatology·2026
Responses to Tetanus and Meningococcal Vaccines in Patients with Alopecia Areata Treated with Ritlecitinib.
Dermatology and therapy·2026
A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2025
Blood Pressure Reactivity and Urinary Abnormalities in Young Athletes.
Journal of hypertension·2026
Diagnostic recognition of primary aldosteronism in clinical practice.
Journal of hypertension·2026
Sarcolipin is a Conformation-Dependent Regulator of the Sarcoplasmic Reticulum Calcium Pump SERCA.
The Journal of membrane biology·2026
Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.
Journal of immunology (Baltimore, Md. : 1950)·2026
Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.
Handbook of experimental pharmacology·2026
Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?
The Journal of clinical endocrinology and metabolism·2026